NSD2 targeting reverses plasticity and drug resistance in prostate cancer.
Li JJ, Vasciaveo A, Karagiannis D, Sun Z, Gretarsson KH, Chen X, Ouerfelli O, Socciarelli F, Frankenstein Z, Dong H, Zou M, Yuan W, Yang G, Aizenman GM, Pannellini T, Xu X, Beltran H, Chen Y, Gardner K, Robinson BD, de Bono J, Gozani O, Abate-Shen C, Rubin MA, Loda M, Sawyers CL, Califano A, Lu C, Shen MM.
Li JJ, et al. Among authors: robinson bd.
Nature. 2026 Jan;649(8095):216-226. doi: 10.1038/s41586-025-09727-z. Epub 2025 Nov 26.
Nature. 2026.
PMID: 41299174
Free PMC article.